Viewing Study NCT03445533

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:42 AM

Ignite Modification Date: 2025-12-26 @ 1:21 AM

Study NCT ID: NCT03445533

Status: TERMINATED

Last Update Posted: 2022-11-08

First Post: 2018-02-13

Is NOT Gene Therapy: False

Has Adverse Events: True

Brief Title: A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma

Sponsor: Idera Pharmaceuticals, Inc.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module